1. Home
  2. CLBK vs MLYS Comparison

CLBK vs MLYS Comparison

Compare CLBK & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Financial Inc.

CLBK

Columbia Financial Inc.

HOLD

Current Price

$21.28

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$28.26

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBK
MLYS
Founded
1927
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
CLBK
MLYS
Price
$21.28
$28.26
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$17.00
$48.67
AVG Volume (30 Days)
442.6K
1.7M
Earning Date
04-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
563.64
37.43
EPS
0.13
N/A
Revenue
N/A
N/A
Revenue This Year
$3.97
N/A
Revenue Next Year
$11.43
N/A
P/E Ratio
$162.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.66
$12.59
52 Week High
$21.59
$47.65

Technical Indicators

Market Signals
Indicator
CLBK
MLYS
Relative Strength Index (RSI) 60.99 55.98
Support Level $19.63 $25.88
Resistance Level $21.39 $31.29
Average True Range (ATR) 0.46 1.47
MACD 0.03 0.43
Stochastic Oscillator 86.70 58.79

Price Performance

Historical Comparison
CLBK
MLYS

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Share on Social Networks: